TAKEDA PHARMACEUTICAL CO LTD NPV earnings per share and revenue

0RN3 earnings per share for the last quarter are -0.01 EUR whereas the estimation was 0.01 EUR which accounts for -290.04% surprise. Företagets omsättning för samma period uppgår till 6.43 B EUR trots den uppskattade siffran 5.55 B EUR. Estimated earnings per share for the next quarter are 0.19 EUR, and revenue is expected to reach 6.27 B EUR. Also watch annual changes over time to get a bigger picture of 0RN3 earnings per share and revenue dynamics.